139 related articles for article (PubMed ID: 8845250)
41. [Comparison between portography-CT and lipiodol-CT in the staging of hepatocellular carcinoma].
Gattoni F; Dova S; Pozzato C; Millefiori M; Uslenghi C
Radiol Med; 1995 Jun; 89(6):813-7. PubMed ID: 7644734
[TBL] [Abstract][Full Text] [Related]
42. Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: CT and pathologic findings.
Choi BI; Kim HC; Han JK; Park JH; Kim YI; Kim ST; Lee HS; Kim CY; Han MC
Radiology; 1992 Mar; 182(3):709-13. PubMed ID: 1311116
[TBL] [Abstract][Full Text] [Related]
43. [Computerized tomography with lipiodol in the assessment of hepatocellular carcinoma].
Gattoni F; Dova S; Volterrani F; Blanc M; Uslenghi C
Radiol Med; 1995 Jun; 89(6):809-12. PubMed ID: 7644733
[TBL] [Abstract][Full Text] [Related]
44. US contrast enhancement with intra-arterial CO2 injection in the staging of hepatocellular carcinomas.
Garbagnati F; Milella M; Spreafico C; Marchianò A; Frigerio LF; Di Tolla G; Patelli G; Lanocita R
Radiol Med; 1994 May; 87(5 Suppl 1):65-70. PubMed ID: 8209020
[TBL] [Abstract][Full Text] [Related]
45. [Lipiodol-CT for the detection of small hypovascular HCC].
Ibukuro K; Fukuda H; Mori K; Sato S; Inoue Y; Fujino H; Uta Y; Tagawa H; Unuma N; Shichijo Y
Rinsho Hoshasen; 1990 Sep; 35(9):1011-4. PubMed ID: 2172600
[TBL] [Abstract][Full Text] [Related]
46. [Evaluation of the efficacy of oil chemoembolization for hepatocellular carcinoma by computed tomography: a proposal for altering the criteria to indicate the efficacy].
Ikeya S; Takayasu K; Muramatsu Y; Moriyama N; Hasegawa H; Hirohashi S
Gan No Rinsho; 1990 Aug; 36(9):985-92. PubMed ID: 2166173
[TBL] [Abstract][Full Text] [Related]
47. Dense parenchymal accumulation of Lipiodol after transarterial chemoembolization.
Hihara T; Araki T; Kachi K; Monzawa S; Uchiyama G
Radiat Med; 1992; 10(3):79-81. PubMed ID: 1324510
[TBL] [Abstract][Full Text] [Related]
48. Correlation between tumor perfusion and lipiodol deposition in hepatocellular carcinoma after transarterial chemoembolization.
Yang L; Zhang XM; Zhou XP; Tang W; Guan YS; Zhai ZH; Dong GL
J Vasc Interv Radiol; 2010 Dec; 21(12):1841-6. PubMed ID: 20980165
[TBL] [Abstract][Full Text] [Related]
49. [Usefulness of enhanced US by CO2 microbubbles for segmental-subsegmental TAE for hepatocellular carcinoma].
Ohno K; Fujita M; Nakamura T; Sato O; Maeda T
Nihon Rinsho; 1998 Apr; 56(4):994-1000. PubMed ID: 9577623
[TBL] [Abstract][Full Text] [Related]
50. [Volumetric and morphological CT parameters for assessing prognosis and treatment control in hepatocellular carcinoma undergoing arterial chemoembolization].
Vogl TJ; Trapp M; Pegios W; Mack M; Bechstein WO; Keck W; Scholz A; Schröder H; Neuhaus P; Felix R
Rofo; 1997 Sep; 167(3):219-26. PubMed ID: 9376548
[TBL] [Abstract][Full Text] [Related]
51. Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization.
Sumie S; Yamashita F; Ando E; Tanaka M; Yano Y; Fukumori K; Sata M
AJR Am J Roentgenol; 2003 Nov; 181(5):1327-34. PubMed ID: 14573429
[TBL] [Abstract][Full Text] [Related]
52. Acute respiratory distress syndrome after transcatheter arterial chemoembolization of hepatocellular carcinomas.
Wu GC; Perng WC; Chen CW; Chian CF; Peng CK; Su WL
Am J Med Sci; 2009 Nov; 338(5):357-60. PubMed ID: 19826242
[TBL] [Abstract][Full Text] [Related]
53. Hepatic neoplasms: detection with hepatoportal subtraction angiography--a new technique of DSA.
Takahashi K; Saito K; Tamura K; Honda M; Touei H; Sakai O; Kawashima Y; Kuji T; Ohtani M; Kawamoto T
Radiology; 1990 Oct; 177(1):243-8. PubMed ID: 2169065
[TBL] [Abstract][Full Text] [Related]
54. Transarterial ethanol ablation of hepatocellular carcinoma with lipiodol ethanol mixture: phase II study.
Yu SC; Hui EP; Wong J; Wong H; Mo F; Ho SS; Wong YY; Yeo W; Lai PB; Chan AT; Mok TS
J Vasc Interv Radiol; 2008 Jan; 19(1):95-103. PubMed ID: 18192473
[TBL] [Abstract][Full Text] [Related]
55. [Imaging diagnosis of hepatocellular carcinomas].
Matsui O; Kadoya M; Kameyama T; Yoshikawa J; Arai K; Gabata T; Takashima T; Ida M; Miyata S
Gan To Kagaku Ryoho; 1989 Jan; 16(1):25-33. PubMed ID: 2536268
[TBL] [Abstract][Full Text] [Related]
56. Value of hepatic arterial phase CT versus lipiodol ultrafluid CT in the detection of hepatocellular carcinoma.
Colagrande S; Fargnoli R; Dal Pozzo F; Bindi A; Rega L; Villari N
J Comput Assist Tomogr; 2000; 24(6):878-83. PubMed ID: 11105704
[TBL] [Abstract][Full Text] [Related]
57. Image fusion of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) using volume navigation for detection, characterization and planning of therapeutic interventions of liver tumors.
Rennert J; Georgieva M; Schreyer AG; Jung W; Ross C; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2011; 49(1-4):67-81. PubMed ID: 22214679
[TBL] [Abstract][Full Text] [Related]
58. Small hepatocellular carcinomas: two-phase dynamic incremental CT in detection and evaluation.
Ohashi I; Hanafusa K; Yoshida T
Radiology; 1993 Dec; 189(3):851-5. PubMed ID: 8234715
[TBL] [Abstract][Full Text] [Related]
59. Lipiodol enhanced CT scanning of malignant hepatic tumors.
Eurvilaichit C
J Med Assoc Thai; 2000 Apr; 83(4):398-406. PubMed ID: 10808700
[TBL] [Abstract][Full Text] [Related]
60. Estimation of the kinetics of iodized oil injected into the feeding artery of hepatocellular carcinoma using dynamic computed tomography.
Inoue H; Miyazono N; Miyake S; Nishida H; Kanetsuki I; Hori A; Mukai H; Ueno K; Nakajo M
Radiat Med; 1994; 12(2):53-8. PubMed ID: 8079003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
